In a trial of streptokinase versus recombinant tissue.type plasmi. nogen activator (rt·PA) for a first myocardial infarction, 270 patients were randomized. Regional left ventricular function was assessed in 214 patients at 3 weeks. The infarct·related artery was the left anterior descending artery in 78 patients, the right coronary artery in 122 and a dominant left circumflex artery in 14. Analysis was by the centerline method with a novel correction for the area of myocardium at risk, whereby the search region was determined by the anatomic distribution of the infarct·related artery.
In a trial of streptokinase versus recombinant tissue.type plasmi. nogen activator (rt·PA) for a first myocardial infarction, 270 patients were randomized. Regional left ventricular function was assessed in 214 patients at 3 weeks. The infarct·related artery was the left anterior descending artery in 78 patients, the right coronary artery in 122 and a dominant left circumflex artery in 14. Analysis was by the centerline method with a novel correction for the area of myocardium at risk, whereby the search region was determined by the anatomic distribution of the infarct·related artery.
Infarct·artery patency at 3 weeks was 73% in the streptokinase group and 71% in the rt-PA group. Global left ventricular function did not differ between the two groups. Mean chord motion (± SD) in the most hypokinetic half of the defined search region was similar in the streptokinase and rt·PA groups (-2.4 ± 1.5 versus -2.3 ± 1.3, P = 0.63). There were no differences in hyperkinesia of the noninfarct zone. Compared with conventional Thrombolytic therapy is clearly indicated in threatened acute myocardial infarction; the efficacy of streptokinase (1, 2) , recombinant tissue-type plasminogen activator (rt-PA) (3) and anistreplase (APSAC) (4) have been demonstrated in controlled mortality trials. Current studies are attempting to determine if a particular thrombolytic agent provides greater patient benefit, and to establish optimal adjunctive therapy.
Tissue plasminogen activator appears to be more effective than streptokinase in achieving early recanalization of the infarct-related artery (5, 6) , but this difference has not been proved to produce measurable clinical benefit. The GISSI-2 trial (7) showed no difference between rt-PA and streptokinase for a combined endpoint of mortality and severe left ventricular impairment, and the larger International Study Group trial (8) showed no difference in hospital mortality between the two agents. centerline analysis, regional wall motion in the defined area at risk was significantly more abnormal. The two methods correlated strongly, however (r = 0.99, p < 0.0001), and both methods produced similar overall results.
Patients with a patent infarct·related artery and those with an occluded artery at the time of catheterization had similar levels of global function (ejection fraction 58 ± 12% versus 57 ± 12%, P = 0.58). Regional function was also similar in patients with a patent and an occluded infarct-related artery on univariate analysis (-2.3 ± 1.5 versus -2.6 ± 1.1 SD, p = 0.14), but multivariate analysis correcting for variation due to infarct site showed that a patent infarct artery was associated with improved regional function (p = 0.007).
Streptokinase and rt-PA in the doses given have similar effects on global and regional left ventricular function measured 3 weeks after a first myocardial infarction.
(J Am Coil CardioI1991; 17:1039-46) Left ventricular function has consistently been shown to be the most important prognostic factor after myocardial infarction, both currently and in the years before thrombolytic therapy was available (9) (10) (11) (12) . Studies generally show better preservation of left ventricular function with thrombolytic therapy compared with placebo (13-21). We previously reported (22) that global left ventricular function measured 3 weeks after initial myocardial infarction was identical in patients treated with streptokinase and rt-PA followed by early intravenous heparin. This report presents results of left ventricular regional wall motion analysis in patients randomized to receive streptokinase or rt-PA in that study.
Variable changes in the function of the noninfarct zone may reduce the accuracy with which global ejection fraction represents infarct zone hypokinesia (23) . Most of the variability in infarct size in canine models of acute infarction is due to variation in the anatomic area at risk (24) . Failure to correct for differences in the extent of myocardium supplied by the infarct-related artery may limit the ability to detect biologically important differences in myocardial salvage produced by different agents. We therefore used a novel modification of the centerline method to assess regional wall motion corrected for the area of myocardium at risk.
Methods
Study patients. Two hundred seventy patients with a first myocardial infarction were randomized in a double blind trial of rt-PA versus streptokinase. The primary end point was global ejection fraction measured by contrast ventriculography 3 weeks after infarction (22) .
All patients were enrolled within 3 h of the onset of typical ischemic chest pain of 2:30 minutes' duration. The following electrocardiographic (ECG) criteria were required in two or more leads: ST segment elevation of 2:0.1 m V in the limb leads or leads V 4 to V 6 or 2:0.2 m V in leads V I to V 3 • Patients with left bundle branch block were excluded. Patients older than 70 years, those with a history of myocardial infarction, and those with a specific contraindication to thrombolytic therapy were not randomized. Specific contraindications to thrombolysis included previous cerebrovascular accident, documented peptic ulceration within 6 months, hypertension (systolic pressure >200 mm Hg), a history of hemorrhagic diathesis or current oral anticoagulant therapy, history of urinary tract bleeding, and surgery or significant trauma in the preceding 2 weeks. Patients with cardiogenic shock were included. All patients gave written informed consent, and the study was approved by the ethics committees of the four participating hospitals.
Treatment protocol. Patients were randomized to receive either rt-PA (10 mg bolus, 50 mg 1st hand 40 mg over the next 2 h) or streptokinase (1.5 million U over 30 min) by a double-blind, double dummy technique. A combination of aspirin, 25 mg, and dipyridamole, 200 mg (Assasantin, Boehringer Ingelheim), was administered orally at the start of thrombolytic therapy and continued twice daily. This dose of aspirin was chosen with the aim of effectively inhibiting platelet cyclooxygenase with relative preservation of endothelial prostacyclin production (25), although we have subsequently adopted a dose of 150 mg/day in view of the results of the ISIS-2 trial (2). Heparin infusion was begun 30 min after the beginning of blinded thrombolytic infusion and continued for 48 h. The initial dose was 1,000 U/h with subsequent dose adjustments to maintain the activated partial thromboplastin time within the range of 90 to 110 s. Beta-adrenergic blocking therapy was begun on the 3rd hospital day in patients without contraindications.
Cardiac catheterization. Coronary angiography and left ventriculography were delayed until 3 weeks after infarction to minimize the effects of myocardial stunning (26) . Left ventricular volumes were calculated from the 30° right anterior oblique ventriculogram by an integration method with correction factors based on a comparison between true and calculated volumes of radiopaque left ventricular casts made from hearts at autopsy (27) . The infarct-related coronary artery was identified by correlating the coronary anatomy with the site of ST elevation on the admission ECG and the distribution of impairment of contractility in the biplane left ventriculogram. Patency of the infarct-related artery was classified according to the criteria of the TIMI trial (6). Regional wall motion analysis: centerline method. Regional wall motion was analyzed by the centerline method (28) , with modification to correct for the area of myocardium at risk. As for left ventricular volume estimation, the endsystolic and end-diastolic contours of well opacified ventricle during sinus rhythm in the 30° right anterior oblique projection were traced onto paper and subsequently entered into a computer with an X -Y digitizer. Ventriculograms were filmed at 50 frames/s and a grid filmed at the level of the patient's heart was used for calibration. No attempt was made to correct for rotational changes, as such corrections increase rather than decrease variability (29) .
The computer generated the centerline between the systolic and diastolic contours and 100 equally spaced chords were drawn perpendicular to the centerline (Fig. 1 ). Chord 1 was drawn at the intersection of the aortic contour and the anterobasal left ventricular wall and chord 100 at the junction of the left ventricular contour and the posterior aortic contour. The measured motion of each chord was normalized for heart size by dividing by the length of the enddiastolic perimeter, and normalized motion for each chord then expressed in terms of standard deviation units (SD) above or below normal mean motion of that chord (Fig. 2) . Normal chord motion for our laboratory was derived from ventriculograms of 52 patients with normal left ventricular function and no coronary artery or valvular disease.
The area of myocardium at risk was defined as the area depicted on the 30° right anterior oblique ventriculogram supplied by the infarct-related coronary artery. For the purposes of this analysis patients with infarction apparently caused by a nondominant circumflex coronary artery lesion were excluded. Wall motion in these patients is better assessed on the left anterior oblique ventriculogram, and changes in nonischemic zone function may confound interpretation of a non dominant circumflex territory infarct as viewed on the right anterior oblique ventriculogram (30) . A dominant circumflex coronary artery was analyzed as a right coronary artery. The proximal limit of the area at risk was taken from the "culprit" lesion, defined as either the lesion associated with thrombus or the most proximal severe stenosis. The distal limit of the area at risk was defined as the termination of the infarct-related artery as viewed in right anterior oblique projection. The proximal and distal limits were marked on the diastolic contour and the chords encompassed were described as "at risk." As is usual in centerline analysis, chords 1 to 9 and 81 to 100 were excluded from analysis because they reflect movement of the aortic root and mitral valve, respectively. A sliding window half the length of the area at risk was used to assess mean chord motion in the most hypokinetic half of the area at risk. The computer automatically positioned the window by testing all possible fits and selecting that in which mean hypokinesia was greatest. We also calculated mean hypokinesia across the entire search area by dividing the sum of hypokinesia of all hypokinetic chords in the area by the total number of chords in the search region. In addition to analyzing mean chord motion in both the total area at risk and the most hypo kinetic half, the circumferential extent of wall motion abnormality was determined by quantifying the percent of chords within the area at risk with motion that deviated from the mean by specified quanta. We measured the percent of chords with motion> 1, 2 and 3 SD below normal. The circumferential extent of akinesia was calculated as the percent of chords in the search region with normalized motion ~O. Hyperkinesia was examined in those chords supplied by the artery not implicated in the index infarct. Mean hyperkinesia was calculated as the sum of hyperkinesia in all hyperkinetic chords subtended by the noninfarct artery CROSS ET AL.
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divided by the total number of chords in the noninfarct region (regardless of their motion).
In addition to the area at risk analysis, the ventriculograms were analyzed by the conventional centerline method by using a sliding window 50% of the length of the assumed territory of the infarct artery, defined as chords 10 to 66 for a left anterior descending artery infarct and chords 51 to 80 for a right coronary or dominant circumflex artery infarct (28) . The primary end point, as in the area at risk analysis, was mean chord motion in the most hypo kinetic half of the search region. Mean hypokinesia of the total search region was also calculated by dividing the summed hypokinesia of all hypo kinetic chords in the area by the length of the search area (57 chords for a left anterior descending infarct and 30 chords for a right coronary infarct). Hyperkinesia was similarly assessed by summing the degree of hyperkinesia of all hyperkinetic chords in the territory of the other artery (chords 67 to 80 for an anterior descending infarct and chords 10 to 50 for a right coronary infarct) (28) , and dividing by the length of the noninfarct search region.
All analyses were performed without knowledge of treatment allocation or patient outcome.
Statistical considerations. Effects of single classifying variables on continuous variables were assessed by one way analysis of variance, and the influence of classifying variables and their interaction (such as the effects of infarct site, thrombolytic therapy and their interaction on regional wall motion) was assessed by multifactorial analysis of variance. Categorical variables were compared using contingency tao ble analysis, with Yates correction for continuity in 2 x 2 tables. Relations between continuous variables were exam· ined by least-squares linear regression. All p values reported are 2-tailed, and p values <0.05 for primary end points are considered significant. The p values reported in subgroup analyses have not been corrected for multiple comparisons. Because the subgroup analyses involve six different hypothesis tests, we considered p values <0.008 significant.
The initial sizing calculations for the trial were designed to give 80% power to detect a 4% absolute difference in global ejection fraction at (l' = 0.05 (22) . The regional wall motion analysis has 74% power to detect an absolute difference of 0.5 SD and 97% power to detect a difference of 0.75 SD at (l' = 0.05. Values are reported as mean values ± SD.
Results
Patient characteristics (Table 1) . Two hundred seventy patients were randomized to receive either streptokinase or rt·PA, of whom 240 had technically satisfactory ventriculo· grams at 3 weeks. Among the other 30 patients, 14 withdrew from the study, 14 died before ventriculography was performed and 2 had technically inadequate ventriculograms. Twenty-six other patients were excluded from the regional wall motion analysis because the infarct-related artery was a nondominant circumflex vessel. Thus, the final group consisted of 214 patients. The time from onset of chest pain to initiation of thrombolytic therapy was 2.2 ± 0.6 h in the rt-PA group and 2.2 ± 0.7 h in the streptokinase group. Global left ventricular function ( Table 2) . As reported for the full group of 240 patients (22) , there was no significant difference in global ejection fraction or left ventricular volumes between streptokinase-and rt-PA-treated patients in this subset of 214 patients. The infarct-related artery was patent in 73% of patients receiving streptokinase and in 71 % of patients receiving rt-PA.
Area at risk analysis. Mean chord motion (Table 3) . Mean chord motion in the most hypokinetic half of the area at risk was the same in patients treated with streptokinase and rt-PA (-2.4 ± 1.5 versus -2.3 ± 1.3, respectively). Similarly, mean hypokinesia across the entire area at risk was not significantly different between the two groups. Mean hyperkinesia in the noninfarct zone was also similar in patients treated with streptokinase and rt-PA. coronary or dominant circumflex artery distribution) infarction showed that regional hypokinesia was more marked with anterior infarction (mean chord motion -3.1 ± 1.2 SD versus -1.9 ± 1.4 SD, p < 0.000l). Averaged chord motion was not significantly different between patients treated with streptokinase and rt-PA in either the anterior or inferior infarct subgroups.
Analysis of the subgroups of patients with anterior (left anterior descending artery distribution) or inferior (right
Circumferential extent of hypokinesia (Table 4) . Overall, there was no significant difference in the circumferential extent of wall motion abnormality in patients treated with streptokinase or rt-PA, although there was a trend toward fewer chords being akinetic in the rt-PA group (22 ± 29% versus 16 ± 24%, p = 0.09). There was no significant heterogeneity of difference between the extent of hypokinesia in rt-PA and streptokinase-treated patients in the subgroups with anterior and inferior infarction (p > 0.2). A trend toward a shorter extent of akinesia and severe hypokinesia (2:3 SD below average) in patients treated with rt-PA in the subgroup with inferior infarction did not reach statistical significance when adjusted for multiple comparisons.
Uncorrected centerline analysis (Table 5 ). Regional wall motion was also similar in streptokinase and rt-PA groups when assessed by the conventional centerline method (mean chord motion -2.3 ± 1.5 SD versus -2.2 ± 1.3 SD, respectively). Hyperkinesia in the noninfarct regions was also similar in the two groups when assessed without correction for individual variations in coronary anatomy.
Comparison of the area at risk method with conventional centerline analysis. The aim of adjusting the search area according to the anatomic distribution of the infarct artery was to produce a search window more accurately matched to the likely area of hypokinesia, and thus to maximize the chance of detecting small differences between the two thrombolytic agents. For anterior infarction the resultant search area was smaller than that used in conventional centerline analysis of one vessel disease in all but one patient (median 47 versus 57 chords). The area at risk method for inferior infarction produced a median search window of 27 chords, compared with 30 for the conventional centerline CROSS ET AL. REGIONAL WALL MOTION AFTER THROMBOLYSIS Tables 3 and  5 are identical. As expected, considering the analysis invariably included overlapping areas of interest, the correlation between mean chord motion assessed by the area-at-risk method and conventional centerline method was high (r = 0.99, p < 0.0001).
The differences between the two methods were most marked in anterior infarction caused by a short left anterior descending coronary artery because the difference between the two methods is related to the length of the search window used for the area at risk analysis (Fig. 3) (r = -0.57,
Effect of infarct-related artery patency (Table 6) . Global left ventricular ejection fraction was similar in patients with a patent infarct-related artery at the time of cardiac catheterization (58 ± 12%) and those with an occluded artery (57 ± 12%). Global function did not differ significantly between patients with an open or occluded infarct artery, regardless of infarct location.
Regional hypokinesia assessed by the area at risk method was also similar in patients with a patent or occluded infarct-related artery on univariate analysis. Subgroup analysis of patients with inferior infarction showed that regional hypokinesia was significantly less severe in patients with a patent infarct artery (-1.7 ± 1.5) than in those with an occluded infarct artery (-2.4 ± 1.1, P = 0.008). Interpretation of these results is complicated by the fact that mean chord motion was more abnormal in patients with an anterior infarct (-3.1 ± 1.2) than in those with an inferior infarct (-1.9 ± 1.4, P < 0.0001) and that patients with an inferior infarct were more likely than those with anterior infarction to have an occluded infarct artery (35% versus 18%, p = 0.014). Multifactor analysis of variance showed that after correction for variation attributable to infarct site, a patent infarct artery was independently associated with improved regional function (p = 0.007). Hyperkinesia of the remote region was not affected by infarct artery patency. Analysis by the conventional centerline method yielded similar results (data not shown).
Discussion
Comparison of streptokinase and rt·PA. One of the major unresolved issues in the management of acute myocardial infarction is whether there are important differences in efficacy between the various thrombolytic agents. Although the TIMI phase 1 trial (6) and European Cooperative Study Group trial (5) showed higher early patency rates after rt-PA than after streptokinase, a convincing clinical advantage due to this difference has not been demonstrated.
The GISSI-2 (7) and International Study Group (8) showed no difference between the two agents in terms of early mortality, excluding with 90% certainty an absolute early mortality difference of> 1.5% (at a = 0.01) between the two agents as administered in those studies. In addition to the current trial, comparative left ventricular function data are available from the TIMI phase 1 trial (31, 32) and the Plasminogen Activator Italian Multicenter Study (PAlMS) (33) .
In the TIMI phase 1 study half the patients underwent repeat arteriography before discharge and had contrast ventriculograms suitable for quantitative analysis (31) . In that study global ejection fraction and regional wall motion were identical in patients treated with streptokinase and rt-PA, although more patients in the rt-PA group had both early reperfusion and a patent artery at the second angiographic study (50% versus 27%, p < 0.01). Most patients (79%) in the TIMI phase 1 study also underwent equilibrium radio nuclide ventriculography before hospital discharge (32) . Again there was no difference in global ejection fraction between the two treatment groups, although a trend toward better regional ejection fraction in the area subtended by the infarct artery in patients treated with rt-PA was observed (40% versus 36%, 0.05 < P < 0.06).
In PAlMS (33) , left ventricular function as assessed by contrast left ventriculography was similar in patients treated with streptokinase and those treated with rt-PA. Satisfactory echocardiograms, obtained in a subset of the patients (68%) before discharge, demonstrated a benefit of borderline statistical significance in favor of rt-PA in terms of global ejection fraction, but not for a semiquantitative wall motion index.
The present study, which included only patients with a first infarction, also shows that there is little or no difference between the two agents in terms of preservation of left ventricular function. The trend toward improved regional function, as measured by the circumferential extent of wall motion abnormality, in patients with inferior infarction treated with rt-PA was not statistically significant. In any case, the circumferential extent of wall motion abnormality is probably a less reliable measure of regional function than mean wall motion because the length of the abnormally contracting zone may be substantially influenced by tethering from the neighboring "normal" zone (28) .
Delaying heparin therapy until 12 h after thrombolytic therapy in the GISSI-2 (7) and International Study Group trials (8) may have negated the benefits of the superior early reperfusion with rt-PA therapy by allowing early reocclusion of the infarct artery. This possibility is being addressed by the ongoing ISIS-3 and Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) studies, but it is pertinent that intravenous heparin was administered in TIMI phase 1 (6), PAlMS (33) and the current study.
Advantages of the area at risk method. Targeting the search area for regional wall motion assessment to the area subtended by the infarct-related artery in each individual patient partially controls for one source of variation between the two treatment groups. In the conscious dog model of myocardial infarction, 66% of the variation in infarct size in control dogs is attributable to variation in the anatomic area at risk (24) .
The results of the area at risk method and conventional centerline analysis are strongly correlated, and the overall results of this trial are similar by both methods. Mean regional wall motion in individual patients is significantly more abnormal by the area at risk method, particularly for anterior infarction related to a short left anterior descending vessel.
It is not established whether the correction for area at risk provides better correlation with other indexes of myocardial damage than the standard centerline method, or whether it provides independent prognostic information. We believe that the method may be particularly useful in smaller trials where failure to correct for variation in patterns of coronary artery supply may limit the ability to detect important differences between treatment groups.
Effects of infarct-related artery patency. The dissociation between late patency of the infarct-related artery and global left ventricular function is an unexpected finding. Patients in whom early reperfusion occurs should have better late left ventricular function due to myocardial salvage. However, late changes in infarct-related artery patency are common after thrombolytic therapy (31, 34) , and crossover between groups, with an initially blocked artery opening late and vice versa, may explain the apparent paradox.
This result does, however, cast some doubt on the effect of late changes in infarct artery patency on left ventricular function. It has been suggested that restoration of anterograde coronary blood flow beyond the time window when myocyte salvage is likely may improve late left ventricular function by limiting infarct area expansion and subsequent left ventricular remodelling (35) (36) (37) . If these changes were substantial, one would expect that patients with a patent artery at 3 weeks (including both those in whom it had been opened early and remained patent and those in whom the artery achieved late patency) would have better global function than those in whom it had never opened or reoccluded later. We did not observe such a difference.
Conclusions. Regional left ventricular function, assessed 3 weeks after initial myocardial infarction by a novel modification of the centerline method with correction for the area of myocardium at risk, was similar in patients randomized to receive streptokinase or rt-PA. These results provide further evidence that despite the fact that rt-PA achieves more rapid clot lysis than streptokinase, there does not appear to be a substantial difference in terms of preservation of left ventricular function, which is the major predictor of long-term survival.
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